EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Therapeutic Potential of Saffron Extract in Mild Depression: A Study of Its Role on Anhedonia in Rats and Humans

Eleonora Corridori, Sara Salviati iD, Maria Graziella Demontis, Pamela Vignolini, Chiara Vita, Andrea Fagiolini, Alessandro Cuomo, Pietro Carmellini, Carla Gambarana iD, Simona Scheggi iD

Phytotherapy Research · 2025-03 · 39 (3) · 1277-1291

DOI: 10.1002/ptr.8424 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Phytotherapy Research, online erschienen am 04.01.2025. Verfasst von Eleonora Corridori und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Developmental Medicine, School of Medicine, University of Siena, Polo Universitario San Miniato, Siena, Italy. Hauptthemen laut MEDLINE: Crocus, Anhedonia, Plant Extracts, Antidepressive Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Regione Toscana (UE) 1305/2013 PSR 2014/2020 - Bando Piani Strategici Gruppi Operativi- PS-GO n. 44/2017, University of the East.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drugs generally used in major depressive disorder are considered inappropriate for the more common milder forms. The efficacy of saffron extracts has been demonstrated in mild to moderate depression and in preclinical models of depression. However, evidence of saffron activity on reduced hedonic responsiveness and motivational anhedonia is limited. Since dopamine transmission dysfunctions are crucially involved in anhedonia and saffron seems to positively modulate dopamine release, we studied the potential antidepressant and anti‐anhedonic effects of a standardized formulation of saffron extract in preclinical models of anhedonia‐like behaviors, and patients diagnosed with unipolar or bipolar depression. We tested saffron activity in a rat model of stress‐induced motivational anhedonia using sucrose self‐administration protocols and investigated the molecular underpinnings of this effect focusing on DARPP‐32 phosphorylation pattern in response to a reinforcer and BDNF–TrkB signaling, in the nucleus accumbens and medial prefrontal cortex. In parallel, with a pilot double‐blind placebo‐controlled study we investigated whether saffron add‐on therapy reduced symptoms of depression and anhedonia, measured by the Montgomery–Åsberg Depression Rating Scale. Repeated saffron administration restored motivation and reactivity to reward‐associated cues in anhedonic rats, likely modulating dopaminergic transmission and BDNF–TrkB signaling. In depressed patients, an 8‐week saffron add‐on therapy induced a global improvement in depressive symptoms and a significant reduction in anhedonia. The study supports a pro‐motivational effect of saffron and suggests a potentially useful saffron‐based augmentation strategy in anhedonic patients, albeit with limitations due to small sample size and short trial duration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CrocusAnhedoniaPlant ExtractsAntidepressive AgentsDepressionAnimalsHumansRatsMaleBrain-Derived Neurotrophic FactorDouble-Blind MethodAdultFemaleMiddle AgedPilot ProjectsPhosphorylationNucleus AccumbensDisease Models, AnimalReceptor, trkB

Stichwörter der Autor:innen

Montgomery–Åsberg depression rating scale (MADRS)brain‐derived neurotrophic factor (BDNF)dopaminenucleus accumbensprogressive ratiostress

Substanzen

Plant ExtractsAntidepressive AgentsBrain-Derived Neurotrophic FactorReceptor, trkB

Autor:innen und Institutionen

  • Department of Molecular and Developmental Medicine, School of Medicine, University of Siena, Polo Universitario San Miniato, Siena, Italy.
  • Laboratorio Phytolab-DiSIA, University of Florence, Florence, Italy.
  • PIN-QuMAP, Polo Universitario di Prato, Prato, Italy.
  • Division of Psychiatry, Department of Molecular and Developmental Medicine, School of Medicine, University of Siena, Siena, Italy.

ORCID-Profile: Sara Salviati, Carla Gambarana, Simona Scheggi

Förderung

  • Regione Toscana (UE) 1305/2013 PSR 2014/2020 - Bando Piani Strategici Gruppi Operativi- PS-GO n. 44/2017
  • University of the East

Zitieren

APA

Corridori, E., Salviati, S., Demontis, M. G., Vignolini, P., Vita, C., Fagiolini, A., Cuomo, A., Carmellini, P., Gambarana, C., & Scheggi, S. (2025). Therapeutic Potential of Saffron Extract in Mild Depression: A Study of Its Role on Anhedonia in Rats and Humans. Phytotherapy Research, 39(3), 1277-1291. https://doi.org/10.1002/ptr.8424

Vancouver

Corridori E, Salviati S, Demontis MG, Vignolini P, Vita C, Fagiolini A, et al. Therapeutic Potential of Saffron Extract in Mild Depression: A Study of Its Role on Anhedonia in Rats and Humans. Phytotherapy Research. 2025;39(3):1277-1291. doi:10.1002/ptr.8424

BibTeX
@article{Corridori2025,
  author = {Corridori, Eleonora and Salviati, Sara and Demontis, Maria Graziella and Vignolini, Pamela and Vita, Chiara and Fagiolini, Andrea and Cuomo, Alessandro and Carmellini, Pietro and Gambarana, Carla and Scheggi, Simona},
  title = {Therapeutic Potential of Saffron Extract in Mild Depression: A Study of Its Role on Anhedonia in Rats and Humans},
  journal = {Phytotherapy Research},
  year = {2025},
  volume = {39},
  number = {3},
  pages = {1277--1291},
  doi = {10.1002/ptr.8424}
}
Kostenlos starten →